Wakusawa S, Takeda K, Miyamoto K, Hidaka H
Research Laboratory for Development of Medicine, School of Pharmacy, Hokuriku University, Kanazawa, Japan.
Anticancer Res. 1992 Nov-Dec;12(6B):2021-4.
ML-9, an inhibitor for myosin light chain kinase, and W-7, a calmodulin inhibitor, suppressed the efflux of vinblastine and increased the intracellular accumulation of vinblastine, but W-5, an inactive compound for calmodulin, did not so in rat ascites hepatoma AH66 cells, which have a multidrug-resistant phenotype. In sensitive counterpart AH66F cells, W-7 and ML-9 were less effective. W-7 and ML-9 did not interfere with [3H]azidopine photolabeling of P-glycoprotein in the plasma membrane from AH66 cells. While P-glycoprotein is reported to be superphosphorylated by protein kinases, W-7 did not influence the phosphorylation of the P-glycoprotein in AH66 cells. There may be an unknown Ca(2+)-calmodulin-dependent mechanism in the extrusion of vinblastine from AH66 cells.
肌球蛋白轻链激酶抑制剂ML-9和钙调蛋白抑制剂W-7可抑制长春碱外排并增加其在细胞内的蓄积,但钙调蛋白无活性化合物W-5对具有多药耐药表型的大鼠腹水肝癌AH66细胞无此作用。在敏感的AH66F细胞中,W-7和ML-9的作用较弱。W-7和ML-9不影响AH66细胞膜上P-糖蛋白的[3H]叠氮平光标记。虽然据报道P-糖蛋白可被蛋白激酶超磷酸化,但W-7不影响AH66细胞中P-糖蛋白的磷酸化。AH66细胞中长春碱的外排可能存在未知的钙-钙调蛋白依赖性机制。